Georgia State University

ScholarWorks @ Georgia State University
Public Health Faculty Publications

School of Public Health

10-2015

Alcohol Policies and Alcoholic Cirrhosis Mortality in the United
States
Scott E. Hadland
Harvard University

Ziming Xuan
Boston University

Jason G. Blanchette
Boston University

Timothy C. Heeren
Boston University

Monica H. Swahn
Georgia State University

See next page for additional authors

Follow this and additional works at: https://scholarworks.gsu.edu/iph_facpub
Part of the Public Health Commons

Recommended Citation
Hadland SE, Xuan Z, Blanchette JG, Heeren TC, Swahn MH, Naimi TS. Alcohol Policies and Alcoholic
Cirrhosis Mortality in the United States. Prev Chronic Dis 2015;12:150200. DOI: http://dx.doi.org/10.5888/
pcd12.150200.

This Article is brought to you for free and open access by the School of Public Health at ScholarWorks @ Georgia
State University. It has been accepted for inclusion in Public Health Faculty Publications by an authorized
administrator of ScholarWorks @ Georgia State University. For more information, please contact
scholarworks@gsu.edu.

Authors
Scott E. Hadland, Ziming Xuan, Jason G. Blanchette, Timothy C. Heeren, Monica H. Swahn, and Timothy S.
Naimi

This article is available at ScholarWorks @ Georgia State University: https://scholarworks.gsu.edu/iph_facpub/177

PREVENTING CHRONIC DISEASE
PUBLIC

HEALTH

RESEARCH,

PRACTICE,

Volume 12, E177

AND

POLICY

OCTOBER 2015
ORIGINAL RESEARCH

Alcohol Policies and Alcoholic Cirrhosis
Mortality in the United States
Scott E. Hadland, MD, MPH; Ziming Xuan, ScD, SM; Jason G. Blanchette, MPH;
Timothy C. Heeren, PhD; Monica H. Swahn, PhD, MPH; Timothy S. Naimi, MD, MPH
Suggested citation for this article: Hadland SE, Xuan Z,
Blanchette JG, Heeren TC, Swahn MH, Naimi TS. Alcohol
Policies and Alcoholic Cirrhosis Mortality in the United States.
Prev Chronic Dis 2015;12:150200. DOI: http://dx.doi.org/
10.5888/pcd12.150200.

were also associated with lower alcoholic cirrhosis mortality rates
among both sexes combined (adjusted IRR, 0.89; 95% CI,
0.82–0.97). Policies were more strongly associated with lower
mortality rates among those living in the Northeast and West
census regions than in other regions.

Conclusions
PEER REVIEWED

Stronger alcohol policy environments are associated with lower alcoholic cirrhosis mortality rates. Future studies should identify underlying reasons for racial/ethnic and regional differences in this
relationship.

Abstract
Introduction
Stronger alcohol policies predict decreased alcohol consumption
and binge drinking in the United States. We examined the relationship between the strength of states’ alcohol policies and alcoholic
cirrhosis mortality rates.

Methods
We used the Alcohol Policy Scale (APS), a validated assessment
of policies of the 50 US states and Washington DC, to quantify the
efficacy and implementation of 29 policies. State APS scores (theoretical range, 0–100) for each year from 1999 through 2008 were
compared with age-adjusted alcoholic cirrhosis death rates that occurred 3 years later. We used Poisson regression accounting for
state-level clustering and adjusting for race/ethnicity, college education, insurance status, household income, religiosity, policing
rates, and urbanization.

Results
Age-adjusted alcoholic cirrhosis mortality rates varied significantly across states; they were highest among males, among residents in states in the West census region, and in states with a high
proportion of American Indians/Alaska Natives (AI/ANs). Higher
APS scores were associated with lower mortality rates among females (adjusted incidence rate ratio [IRR], 0.91 per 10-point increase in APS score; 95% confidence interval [95% CI],
0.84–0.99) but not among males (adjusted IRR, 0.97; 95% CI,
0.90–1.04). Among non-AI/AN decedents, higher APS scores

Introduction
Excessive alcohol consumption is the third leading preventable
cause of death in the United States; alcoholic cirrhosis accounts
for nearly half of all cirrhosis deaths (1,2). Although the age-adjusted alcoholic cirrhosis mortality rate in the United States is
lower than the global average (3.3 compared with 5.9 deaths per
100,000 per year), it has steadily and significantly increased during the past decade (1). Moreover, significant differences exist
among demographic subgroups; death rates are particularly high
among American Indians/Alaska Natives (AI/ANs) (3).
Stronger state-level alcohol policies have been linked to decreased binge drinking (4,5). State alcohol policies include diverse interventions such as implementing alcohol excise taxes;
regulating the location, time, and quantity of alcohol sales; and restricting retail signage and media advertising (6,7). To date, most
studies of alcohol-related outcomes have examined single policy
changes (8–11). However, alcohol consumption is simultaneously
affected by multiple policies of varying efficacy and levels of implementation. Therefore, it is critical to consider states’ overall alcohol policy environments. Furthermore, analyses should carefully examine subpopulations, including AI/ANs, who have high
alcohol-related mortality rates and may live in autonomous regions where policies may have poor penetration (3,12).
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Understanding alcohol policy environments and their links to
health may inform policy makers who seek to reduce alcohol-related harm. To examine the association between policies and alcoholic cirrhosis mortality rates, we used the Alcohol Policy Scale
(APS) score, which quantifies states’ alcohol policy environments
by considering not only the efficacy of policies but also their degree of implementation (4). We hypothesized that stronger policy
environments would be associated with lower alcoholic cirrhosis
mortality rates but that this association might not be as robust for
AI/ANs.

Methods
The Alcohol Policy Scale (APS) is a validated assessment of alcohol policies of the 50 US states and Washington, DC, that was described previously (4,6). Briefly, the APS integrated ratings on the
efficacy and degree of implementation of 29 policies collected and
assessed by a Delphi panel. Panel members were experts from academia, government, and the private sector and represented a range
of disciplines, including law, epidemiology, psychology, sociology, and economics.
Each panelist independently nominated alcohol policies considered to effectively reduce excessive drinking or alcohol-related
harm. The primary source for policies was the Alcohol Policy Information System maintained by the National Institute on Alcohol
Abuse and Alcoholism (13). Examples of policies incorporated into a state’s APS score included alcohol taxes, retail price restrictions, and hours of sales regulations; a full list is available elsewhere (6). The APS incorporated information on the efficacy and
legislative implementation of each alcohol policy.
To determine the efficacy of each policy, the study investigators
generated idealized descriptions for each policy. For each stateyear, panelists independently rated the efficacy of each policy for
reducing binge drinking in the general population on the basis of
their expertise and available scientific evidence. Ratings were on a
5-point Likert scale (1 = low efficacy to 5 = high efficacy) and
provided for each state and year. (A separate ratings process examined policy efficacy for reducing binge drinking among youths
and alcohol-impaired driving, but these efficacy ratings were not
considered in these analyses.) Next, panelists met to review the
combined ratings and discuss their individual ratings, focusing on
the strength of the scientific literature supporting each policy. Afterward, each panelist again independently rated each policy a
second time concerning reducing binge drinking in the general
population. These final ratings comprised the efficacy component
of the APS.

To determine the implementation of each alcohol policy, study investigators generated an implementation rating scale on the basis
of the statutory design of each policy, specifically considering provisions that made the policy broadly applicable, effective, or enforceable (4). Panelists then provided feedback on the implementation rating scales, which were subsequently revised by the study
investigators. Then the scales were applied to all policies for each
state and year, with a range of 0 (no policy) to 1.0 (policy with full
implementation).
Ultimately, 29 policies were included in the APS. To generate an
overall APS score for each state and year, each efficacy score was
multiplied by its implementation score and summed with all other
policies for that state and year (4,6). Scores were standardized
such that the theoretical range of the APS score was from 0 to 100;
high APS scores represented strong alcohol policy environments.
APS scores from 1999 through 2008 were used in these analyses.
Age-adjusted alcoholic cirrhosis mortality rates were obtained
from the Centers for Disease Control and Prevention (CDC) WideRanging Online Data for Epidemiologic Research (WONDER)
system. Using the International Classification of Diseases, 10th
Revision, Clinical Modification code K70.x (alcoholic liver disease), we extracted age-adjusted mortality data for all 50 states
and Washington, DC, for all years from 2002 through 2011, and
for males and females separately, resulting in 1,020 observations
(14). The range 2002 through 2011 was selected to allow for a 3year lag between APS score and associated mortality rates. Of the
1,020 state-year observations, 123 (12.1%) were suppressed by the
CDC WONDER system because of insufficient counts for that
state-year to preserve confidentiality. In such cases, a 2-year running average was used, such that the overall mortality rate in a
state for a suppressed year was combined with the rate from the
previous year, which usually provided sufficient counts so that the
rate was no longer suppressed. By this process, 105 (10.3%) missing mortality rates were imputed, leaving only 18 (1.8%) stateyear observations suppressed.
We examined age-adjusted rates for 2010–2011, the most recent
years analyzed, and generated a map comparing APS scores and
age-adjusted alcoholic cirrhosis mortality rates for both sexes
combined to examine geographical differences. Because regional
differences in mortality rates were apparent after constructing this
map, we examined age-adjusted mortality rates by sex according
to US census region (region 1 [Northeast], region 2 [Midwest], region 3 [South], region 4 [West]). Because we hypothesized that
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the association between APS and mortality rate might be modified by race/ethnicity, we also examined mortality rates by sex according to states’ proportion of racial/ethnic subgroups (non-Hispanic white, non-Hispanic black, Hispanic, and AI/AN [including
Hispanic AI/AN]).
We then examined the association between APS and mortality
rates. Each state-year of mortality data was matched to the corresponding APS using a 3-year lag. For example, states’ APS scores
from 1999 were related to mortality rates for 2002. The 3-year lag
was used to increase the number of overlapping years of APS
scores and mortality data (compared with a longer lag, which
would have resulted in fewer overlapping years of data). This
shorter lag period was consistent with evidence showing that alcohol policy changes may demonstrate an early effect on cirrhosis
death rates (15–17).
Analyses used Poisson regression with robust standard error estimates to account for state-level clustering (18). Incidence rate ratios (IRRs) were adjusted for state-level race/ethnicity, college
education, insurance status, household income, religiosity, policing rates, level of urbanization, and study year as an indicator
variable. Covariates were extracted from the US Census Bureau’s
American Community Survey and Current Population Survey and
were time-updated to match the mortality rate for each state-year
observation (19–21). As a sensitivity analysis, we also repeated all
models using a fixed effects approach in which we included an indicator variable for every state and repeated all models using a
random intercepts approach in which state was a level 2 variable;
results were consistent with the findings from the robust sandwich
standard error estimates (not shown).
To examine regional differences in the association between APS
and alcoholic cirrhosis mortality rates, we also conducted analyses stratified by census region. Recognizing that AI/ANs in
many places in the United States have elevated alcohol-related
mortality rates (3) and that state health policies may not penetrate
sovereign or physically remote AI/AN locales (12), we also stratified analyses according to states with proportion of AI/ANs
(≥2.5% or <2.5%). Proportions were time-updated during the
study period. We also repeated analyses using mortality data extracted from CDC WONDER that excluded AI/AN decedents. Finally, we generated scatterplots of states’ proportion of AI/ANs
and alcoholic cirrhosis mortality rates according to sex, using the
most recent years of data examined (2010–2011).
Analyses were performed using STATA version 13/SE (StataCorp LP). All P values were 2-sided, and tests were considered
significant at P < .05.

Results
For all states from 1999 through 2008, the mean APS score was 41
(range, 23–66) and increased during the study period (mean APS
in 1999, 38; mean APS in 2008, 42; P < .001). The mean age-adjusted alcoholic cirrhosis mortality rate for the United States from
2002 through 2011 was 4.7 deaths per 100,000 per year (95% confidence interval [CI], 4.2–5.3) with a range of 2.5 (Pennsylvania)
to 10.3 (New Mexico). Alcoholic cirrhosis mortality rates increased during the study period (mean age-adjusted mortality rate
in 2002 was 4.6 deaths per 100,000; mean rate in 2011 was 5.3
deaths per 100,000; P < .001).
During the 2 most recent years studied (2010–2011), age-adjusted
alcoholic cirrhosis mortality rates for males were significantly
higher than those for females, and there was substantial variability
between states (Table 1). Figure 1 shows states’ mortality rates
and APS score tertiles for both sexes combined. In general, there
was considerable geographic variation in alcoholic cirrhosis mortality rates; rates among states in the West census region were
higher than among those in other US census regions.

Figure 1. State age-adjusted alcoholic cirrhosis mortality rates (men and
women combined) and associated alcohol policy score tertiles. Mortality rates
from 2010–2011 were compared with alcohol policy scores from 2008 to
introduce a 2- to 3-year lag. States with the highest tertile of alcohol policy
score (ie, strongest policy environment) are marked by 3 asterisks (***); the
middle tertile, by 2 asterisks (**); and the lowest tertile, by a single asterisk
(*).

Mean age-adjusted alcoholic cirrhosis mortality rates during the
entire study period (2002–2011) were analyzed according to racial/ethnic group and census region (Table 2). In every comparison, mortality rates were significantly higher among males than
among females. Significant differences in mortality rates were
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noted between females from states with differing proportion of
non-Hispanic blacks (≥5% and <5%) and between states with differing proportions of AI/ANs (≥2.5% and <2.5%) for both sexes.
Region 4 (West) had significantly higher mortality rates than other regions for both sexes.
In unadjusted analyses, APS score was not significantly associated with alcoholic cirrhosis mortality when both sexes were considered together (IRR, 0.93 per 10-point increase in APS score;
95% CI, 0.80–1.07) and separately (male IRR, 0.95; 95% CI,
0.83–1.08; female IRR, 0.86; 95% CI, 0.72–1.04). After adjusting
for covariates, higher APS score was significantly associated with
lower alcoholic cirrhosis mortality rates among females but not
among males, and among the overall population when both sexes
were combined (Table 3).
Additionally, significant geographical variation was seen in the association between APS score and alcoholic cirrhosis mortality
rates. For both sexes, APS score was significantly associated with
decreased mortality rates in the Northeast and South census regions, but not in the Midwest or West regions. Furthermore, the
association of APS score with lower mortality rates was present in
states with less than 2.5% of AI/ANs but not in states with 2.5% or
more AI/ANs. When analyses were repeated excluding all AI/AN
decedents, geographical variation was again present in the association between APS score and alcoholic cirrhosis mortality rates.
For both sexes combined, APS score was significantly associated
with decreased mortality rates in the Northeast and West, a finding that also held when males were analyzed separately; when females were analyzed separately, the association was significant
only in the Northeast.
Scatterplots of state age-adjusted alcoholic cirrhosis mortality
rates by the proportion of AI/ANs are depicted in Figure 2. In general, as the proportion of AI/ANs increased, mortality rates increased.
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Figure 2. Relationship between proportion of American Indians/Alaska Natives
in states’ populations and age-adjusted alcoholic cirrhosis mortality rates of
states among (2a) both sexes [r2 = 0.320, P < .001], (2b) males [r2 = 0.473,
P < .001], and (2c) females [ r 2 = 0.217, P = .001], United States,
2010–2011. Solid line represents curve of best fit determined by the leastsquares method. Hashed lines represent upper and lower 95% confidence
intervals.

Discussion

large number of those individuals are at greater risk of death in the
near future; if per capita alcohol consumption decreases, those
same individuals are at lower risk of immediate mortality. This
phenomenon was observed historically after the institution and
subsequent repeal of prohibition in the United States (15). Our results support that strengthening alcohol policy environments may
be beneficial for the overall population in the short-term, despite
the long lag between alcohol consumption and death from cirrhosis observed at the individual level.

We found that stronger state alcohol policy environments were associated with lower alcoholic cirrhosis mortality rates for certain
regions and racial/ethnic groups in the United States. Using the
APS score, which quantifies a state’s alcohol policy environment,
we found that a 10-point increase (ie, a stronger policy environment) was associated with a 9% decrease in alcoholic cirrhosis
mortality among females. To provide context to this 10-point difference, the range of APS scores observed across states during the
study period was 23 to 66, so there is notable between-state variation in the strength of alcohol policy environments. Examining
mortality rates among non-AI/AN decedents indicated that a 10point increase in APS score was associated with an 11% decrease
in mortality among both sexes, a finding driven primarily by females, whose mortality rate decreased by 18% for a 10-point increase in APS score.

The association of strong alcohol policy environments with mortality rate in the overall population was driven primarily by the
death rate among females. Alcohol policy environments may have
a greater effect on excess alcohol consumption among females
than among males (5,26). We also noted that alcohol policy environments were not as strongly associated with reduced alcoholic
cirrhosis mortality rates when AI/AN decedents were included in
analyses. Our findings are consistent with evidence demonstrating
elevated rates of alcohol-related death among AI/AN populations
relative to other US populations (3) and suggest that changes in alcohol policies may be less protective for AI/AN individuals who
live in autonomous or physically remote regions in which state alcohol policies have poor penetration (12). Additionally, our study
did not examine the potential protective role of tribal alcohol
policies, an area that requires further study (27,28).

These findings are consistent with the recent finding that stronger
state alcohol policy environments in the United States are associated with decreased binge drinking prevalence (4). Coupled with
data suggesting that alcohol consumption is tied to alcoholic cirrhosis mortality at the aggregate level (7,15,22), our results are
consistent with a potentially protective role for alcohol policies in
reducing cirrhosis mortality. State alcohol policies aimed at reducing alcohol consumption in the general population are more
strongly associated with reduced binge drinking than are more targeted policies, such as policies focusing solely on underage drinking or impaired driving (5). Tax and price policies appear to be
particularly effective for reducing adult binge drinking as well as
alcoholic cirrhosis mortality rates and are likely critical components of a robust alcohol policy environment (5,7,11,23,24).

Finally, we noted significant regional variation in the relationship
between alcohol policy environment and mortality rates, with the
strongest association noted in the Northeast census region. Other
studies have shown significant regional variation in the effects of
alcohol policy on drinking-related behaviors (4,9,10,15,26,29), including a recent assessment of alcohol poisoning deaths in the
United States that showed high mortality in the West census region relative to the Northeast and South (30). It is possible that enforcement of alcohol policies may vary across regions and contribute to the differences in effect sizes observed in our study or that
proximity to care varies among states. Future studies should continue to assess the differential effects of alcohol policies on other
health concerns that are linked to excessive alcohol use for specific population subgroups according to sex, race/ethnicity, and geographical location.

Although alcoholic cirrhosis mortality has a long lag period, lasting up to decades of alcohol exposure (25), our findings showed a
significant association between alcohol policy environments and
mortality rates using only a 3-year lag. At the aggregate level,
however, there may be an immediate effect on cirrhosis mortality
demonstrated after sudden declines in alcohol consumption
(7,15,17,25). As suggested previously (7,17), at any given time,
there exists a reservoir of individuals with a prior and extensive
history of drinking and alcoholic cirrhosis who are approaching a
mortality threshold. If per capita alcohol consumption increases, a

This study has several limitations. Although we carefully examined the efficacy and implementation of alcohol policies, the
APS score does not incorporate enforcement of policies given the
absence of any reliable publicly available data on enforcement
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across states. Nonetheless, when designing the APS score, study
investigators and the expert panel incorporated into the implementation ratings policy provisions that made policies more likely
to be enforceable (4,6). Our analyses also controlled for number of
police officers per capita as a state-level covariate to help account
for variations in enforcement.
Additionally, despite using a lag period between exposure and outcome and controlling for year, there remains the possibility of reverse causation between APS score and alcoholic cirrhosis mortality. Specifically, states that had lower consumption of alcohol may
have been the same states that implemented strong alcohol policy
environments. We introduced a 3-year lag between a state’s APS
score and associated mortality rate to allow time for state policies
to be implemented and enforced; this lag helps to establish temporality, even if causation cannot be fully established. We also
cannot exclude residual confounding despite controlling for a
range of state-level covariates. We exclusively studied alcoholic
cirrhosis and did not examine the contribution of other potentially
overlapping causes of cirrhosis, such as hepatitis C. Finally, although the APS incorporates state-level alcohol policies, it does
not include federal or local policies (eg, federal regulations on alcohol marketing, county or municipal taxes on alcohol purchases,
tribal alcohol policies).
This study established an association between the strength of
states’ alcohol policy environments and mortality from a leading
alcohol-attributable cause of death. Future studies should further
assess the strength and directionality of this association. Our findings suggest that strengthening alcohol policy environments may
be an effective intervention for reducing cirrhosis mortality. Researchers and policy makers should additionally consider whether
alcohol policies are uniformly protective for all citizens, given that
significant disparities in mortality rates persist for AI/ANs relative to others.
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Tables
Table 1. Age-Adjusted Alcoholic Cirrhosis Mortality Ratesa Per 100,000 Population Per Year, by State, United States,
2010–2011
Overall
State

Males

Females

Rate (95% Confidence Interval)

US average

4.8 (4.7–4.8)

7.0 (6.9–7.1)

2.7 (2.6–2.8)

New Mexico

11.5 (10.5–12.6)

16.4 (14.6–18.1)

7.1 (5.9–8.2)

Arizona

9.3 (8.7–9.8)

13.1 (12.3–14.0)

5.8 (5.2–6.3)

8.7 (7.0–10.5)

10.8 (8.2–13.8)

6.7 (4.7–9.3)

Oregon

8.5 (7.9–9.2)

11.7 (10.7–12.7)

5.6 (4.9–6.3)

California

8.2 (8.0–8.5)

12.3 (11.9–12.6)

4.6 (4.4–4.8)

Washington

8.2 (7.7–8.7)

11.0 (10.2–11.8)

5.6 (5.0–6.1)

South Dakota

8.1 (6.7–9.5)

10.3 (8.2–12.8)

6.1 (4.5–8.1)

North Dakota

7.8 (6.3–9.3)

10.4 (8.1–13.1)

5.2 (3.6–7.4)

Montana

7.7 (6.5–8.9)

10.3 (8.4–12.2)

5.2 (3.9–6.8)

Colorado

7.5 (7.0–8.1)

10.5 (9.6–11.4)

4.8 (4.2–5.4)

Oklahoma

7.5 (6.9–8.1)

10.3 (9.3–11.3)

4.9 (4.2–5.6)

Alaska

7.4 (6.0–8.9)

8.0 (6.1–10.3)

6.8 (5.0–8.9)

Idaho

7.2 (6.3–8.1)

8.8 (7.3–10.3)

5.7 (4.6–7.0)

Nevada

6.6 (5.9–7.2)

8.3 (7.2–9.3)

4.8 (4.0–5.7)

Vermont

5.5 (4.4–6.8)

7.7 (5.8–10.0)

3.4 (2.2–5.0)

Florida

5.1 (4.9–5.3)

7.5 (7.1–7.9)

3.0 (2.8–3.2)

Nebraska

5.1 (4.4–5.8)

6.7 (5.6–7.9)

3.7 (2.8–4.6)

Rhode Island

4.9 (4.0–5.7)

7.6 (6.1–9.3)

2.5 (1.7–3.5)

Michigan

4.8 (4.5–5.1)

6.9 (6.4–7.4)

2.9 (2.6–3.2)

District of Columbia

4.7 (3.5–6.1)

6.1 (4.2–8.5)

3.4 (2.1–5.2)

South Carolina

4.6 (4.2–5.0)

7.3 (6.5–8.0)

2.3 (1.9–2.7)

Tennessee

4.6 (4.3–5.0)

7.0 (6.4–7.7)

2.4 (2.0–2.7)

Maine

4.5 (3.8–5.2)

6.3 (5.1–7.6)

2.9 (2.2–3.8)

Wisconsin

4.5 (4.1–4.9)

6.3 (5.6–6.9)

2.8 (2.3–3.2)

Iowa

4.4 (3.9–4.9)

6.4 (5.5–7.3)

2.5 (2.0–3.1)

Texas

4.3 (4.2–4.5)

6.7 (6.4–7.1)

2.1 (1.9–2.3)

New Hampshire

4.2 (3.5–4.9)

6.3 (5.1–7.6)

2.4 (1.7–3.3)

West Virginia

4.2 (3.5–4.8)

6.5 (5.4–7.6)

1.9 (1.4–2.6)

Minnesota

4.1 (3.7–4.5)

5.5 (4.9–6.1)

2.8 (2.3–3.2)

Wyoming

Abbreviations: CDC, Centers for Disease Control and Prevention; NA, not applicable; WONDER, Wide-Ranging Online Data for Epidemiologic Research.
a All age-adjusted rates obtained from CDC WONDER database and are averaged for 2010–2011.
b Mortality data for females in Delaware were not available due to insufficient counts in CDC WONDER database.
(continued on next page)
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(continued)

Table 1. Age-Adjusted Alcoholic Cirrhosis Mortality Ratesa Per 100,000 Population Per Year, by State, United States,
2010–2011
Overall
State

Males

Females

Rate (95% Confidence Interval)

Ohio

4.1 (3.8–4.3)

6.1 (5.7–6.6)

2.2 (1.9–2.4)

Kansas

4.0 (3.5–4.5)

6.1 (5.2–7.0)

2.0 (1.6–2.6)

Hawaii

4.0 (3.3–4.7)

6.0 (4.8–7.4)

2.1 (1.4–2.9)

North Carolina

4.0 (3.7–4.2)

6.2 (5.7–6.7)

2.0 (1.7–2.3)

Indiana

3.9 (3.6–4.2)

6.0 (5.4–6.5)

2.0 (1.7–2.3)

New York

3.4 (3.2–3.6)

5.3 (4.9–5.6)

1.7 (1.6–1.9)

Utah

3.4 (2.8–3.9)

4.5 (3.6–5.4)

2.3 (1.8–3.0)

Kentucky

3.2 (2.8–3.7)

4.8 (4.0–5.6)

1.7 (1.3–2.3)

Arkansas

3.2 (2.9–3.6)

5.3 (4.6–6.0)

1.4 (1.0–1.7)

Missouri

3.2 (2.9–3.5)

4.7 (4.2–5.3)

1.7 (1.4–2.0)

Illinois

3.1 (2.9–3.4)

4.5 (4.2–4.9)

1.9 (1.6–2.1)

Mississippi

3.0 (2.6–3.4)

5.0 (4.2–5.8)

1.2 (0.9–1.7)

New Jersey

2.9 (2.7–3.2)

4.4 (3.9–4.8)

1.7 (1.4–1.9)

Georgia

2.9 (2.7–3.2)

4.6 (4.2–5.0)

1.4 (1.2–1.6)

Massachusetts

2.9 (2.6–3.2)

4.4 (3.9–4.9)

1.5 (1.2–1.8)

Alabama

2.9 (2.5–3.2)

4.6 (4.0–5.2)

1.4 (1.1–1.7)

Delaware

2.8 (2.1–3.6)

4.7 (3.4–6.2)

NAb

Pennsylvania

2.8 (2.6–3.0)

4.0 (3.7–4.4)

1.6 (1.4–1.8)

Virginia

2.7 (2.4–2.9)

3.9 (3.5–4.3)

1.6 (1.4–1.9)

Connecticut

2.7 (2.3–3.0)

3.9 (3.3–4.6)

1.6 (1.2–2.0)

Louisiana

2.7 (2.3–3.0)

4.0 (3.4–4.6)

1.5 (1.1–1.8)

Maryland

2.5 (2.2–2.8)

3.7 (3.2–4.2)

1.4 (1.2–1.7)

Abbreviations: CDC, Centers for Disease Control and Prevention; NA, not applicable; WONDER, Wide-Ranging Online Data for Epidemiologic Research.
a All age-adjusted rates obtained from CDC WONDER database and are averaged for 2010–2011.
b Mortality data for females in Delaware were not available due to insufficient counts in CDC WONDER database.
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Table 2. Mean Age-Adjusted Alcoholic Cirrhosis Mortality Rates Per 100,000 Population Per Year, by Mean State-Level
Characteristic, United States, 2002–2011
Mortality Per 100,000 Per Year (95% CI)
State Characteristic
All races/ethnicities and regions

Overall

Males

Females

4.5 (3.5–5.5)

6.7 (5.2–8.2)

2.4 (1.9–2.9)

<80

4.8 (3.4–6.3)

7.2 (5.1–9.4)

2.5 (1.7–3.3)

≥80

4.0 (3.4–4.6)

5.8 (5.1–6.6)

2.2 (1.8–2.6)

<5

5.9 (4.8–6.9)

8.3 (6.7–9.9)

3.5 (2.8–4.1)

≥5

4.1 (3.1–5.1)

6.1 (4.6–7.7)

2.0 (1.5–2.6)

<5

3.9 (3.3–4.4)

5.8 (5.0–6.7)

2.0 (1.7–2.3)

≥5

5.6 (4.1–7.0)

8.1 (6.0–10.3)

3.0 (2.3–3.8)

% Non-Hispanic white

% Non-Hispanic black

% Hispanic

% American Indian/Alaska Native
<2.5

4.2 (3.1–5.3)

6.3 (4.7–8.0)

2.2 (1.6–2.8)

≥2.5

7.4 (6.7–8.0)

10.2 (9.3–11.1)

4.5 (4.1–5.0)

1 (Northeast)

3.0 (2.7–3.3)

4.5 (4.0–5.0)

1.5 (1.4–1.7)

2 (Midwest)

3.7 (3.3–4.1)

5.4 (4.8–6.0)

2.0 (1.8–2.3)

3 (South)

3.8 (3.3–4.4)

5.9 (5.1–6.6)

1.9 (1.5–2.2)

4 (West)

7.6 (6.9–8.3)

10.9 (9.5–12.3)

4.2 (4.0–4.5)

Census region

Abbreviation: CI, confidence interval.
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Table 3. Incidence Rate Ratios (IRRs) for Association of Alcohol Policy Scale (APS) Scorea With State-Level, Age-Adjusted
Alcoholic Cirrhosis Mortality Rates, by US Census Region and by State Proportion of American Indians/Alaska Natives (AI/
ANs), 2002–2011
Adjusted IRR (95% Confidence Interval)b
Subcategory
All

Overall

races/ethnicitiesc

Males

Females

0.95 (0.88–1.03)

0.97 (0.90–1.04)

0.91 (0.84–0.99)

1 (Northeast)

0.68 (0.60–0.78)

0.70 (0.60–0.82)

0.61 (0.58–0.65)

2 (Midwest)

1.01 (0.93–1.09)

1.02 (0.96–1.09)

0.96 (0.81–1.14)

3 (South)

0.87 (0.76–0.99)

0.87 (0.77–0.98)

0.82 (0.71–0.95)

4 (West)

0.87 (0.73–1.03)

0.89 (0.75–1.05)

0.83 (0.68–1.00)

0.90 (0.82–0.98)

0.90 (0.82–0.98)

0.88 (0.81–0.96)

0.98 (0.89–1.08)

0.99 (0.90–1.08)

0.98 (0.86–1.11)

0.89 (0.82–0.97)

0.94 (0.87–1.01)

0.82 (0.69–0.98)

1 (Northeast)

0.55 (0.43–0.72)

0.71 (0.60–0.84)

0.39 (0.25–0.61)

2 (Midwest)

0.99 (0.92–1.07)

1.01 (0.95–1.08)

0.95 (0.80–1.12)

3 (South)

0.79 (0.59–1.06)

0.91 (0.78–1.06)

0.59 (0.35–1.01)

4 (West)

0.89 (0.80–0.99)

0.83 (0.70–0.99)

0.96 (0.85–1.09)

Census

regiond

AI/ANd,e,

%

<2.5
≥2.5
All races/ethnicities, excluding AI/AN

decedentsc

Census region

a A 3-year lag was introduced between APS score and mortality rates (eg, states’ mortality rates from 2002 were associated with APS scores from

1999).
b IRR reported per 10-point increase in APS score; models adjusted for year, race/ethnicity, college education, insurance status, household income, religiosity, policing rates, and proportion living in rural/urban areas.
c IRR is adjusted for all covariates as well as census region and proportion of AI/ANs.
d Model stratified by census region is adjusted for all covariates, as well as proportion of AI/ANs; model stratified by proportion of AI/ANs is adjusted for
all covariates, as well as census region.
e Includes 806 state-year observations with the proportion of AI/ANs <2.5% and 214 observations with proportion ≥2.5%.
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